Publication | Open Access

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

OncologySolid TumorsPharmacologyAlbumin-bound PaclitaxelTreatment SchedulesPharmacotherapyAnti-cancer AgentCancer TreatmentMedicine